References: Authors’ responses to Letter to the Editor regarding ‘Early digoxin-specific antibody fragments to treat patients at risk of life-threatening toxicity’

653

Views

CrossRef citations to date

Altmetric

References

Chan BSH, Buckley NA. Digoxin-specific antibody fragments in the treatment of digoxin toxicity. Clin Toxicol (Phila) 2014; 52:824–836.
PubMed Web of Science ®Google Scholar
Dally S, Alperovitch A, Lagier G, Bismuth C, Fournier E.[Prognostic factors in acute digitalis poisoning (author’s transl)]. Nouv Presse Med 1981; 10:2257–2260.
PubMedGoogle Scholar
Lapostolle F, Borron SW, Verdier C, Taboulet P, Guerrier G, Adnet F, et al. Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoning. Crit Care Med 2008; 36:3014–3018.
PubMed Web of Science ®Google Scholar
Lapostolle F, Borron SW, Verdier C, Arnaud F, Couvreur J, Mégarbane B, et al. Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposure. Intensive Care Med 2008; 34:1448–1453.
PubMed Web of Science ®Google Scholar
Antman EM, Wenger TL, Butler VP Jr, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation 1990; 81:1744–1752.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Authors’ responses to Letter to the Editor regarding ‘Early digoxin-specific antibody fragments to treat patients at risk of life-threatening toxicity’

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Authors’ responses to Letter to the Editor regarding ‘Early digoxin-specific antibody fragments to treat patients at risk of life-threatening toxicity’

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date